Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

597 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E, van Roeyen CR, Van de Leur E, Floege J, Weiskirchen R. Borkham-Kamphorst E, et al. J Cell Commun Signal. 2012 Mar;6(1):11-25. doi: 10.1007/s12079-011-0141-3. Epub 2011 Jul 5. J Cell Commun Signal. 2012. PMID: 21748432 Free PMC article.
The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J. Ostendorf T, et al. J Am Soc Nephrol. 2002 Mar;13(3):658-67. J Am Soc Nephrol. 2002. PMID: 11856769
Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis.
Raffetseder U, Wernert N, Ostendorf T, van Roeyen C, Rauen T, Behrens P, Floege J, Mertens PR. Raffetseder U, et al. Kidney Int. 2004 Aug;66(2):622-32. doi: 10.1111/j.1523-1755.2004.00782.x. Kidney Int. 2004. PMID: 15253715
Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis.
Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, van Roeyen CR, Eitner F, Kawachi H, Starling G, Alvarez E, Smithson G, Floege J. Ostendorf T, et al. J Am Soc Nephrol. 2006 Apr;17(4):1054-62. doi: 10.1681/ASN.2005070683. Epub 2006 Mar 1. J Am Soc Nephrol. 2006. PMID: 16510766
Pro-fibrogenic potential of PDGF-D in liver fibrosis.
Borkham-Kamphorst E, van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Borkham-Kamphorst E, et al. J Hepatol. 2007 Jun;46(6):1064-74. doi: 10.1016/j.jhep.2007.01.029. Epub 2007 Feb 23. J Hepatol. 2007. PMID: 17397961
The role of PDGF-D in mesangioproliferative glomerulonephritis.
Floege J, van Roeyen C, Boor P, Ostendorf T. Floege J, et al. Contrib Nephrol. 2007;157:153-8. doi: 10.1159/000102460. Contrib Nephrol. 2007. PMID: 17495455 Review.
Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.
Borkham-Kamphorst E, Kovalenko E, van Roeyen CR, Gassler N, Bomble M, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Borkham-Kamphorst E, et al. Lab Invest. 2008 Oct;88(10):1090-100. doi: 10.1038/labinvest.2008.71. Epub 2008 Jul 28. Lab Invest. 2008. PMID: 18663351
Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1.
Raffetseder U, Rauen T, Djudjaj S, Kretzler M, En-Nia A, Tacke F, Zimmermann HW, Nelson PJ, Frye BC, Floege J, Stefanidis I, Weber C, Mertens PR. Raffetseder U, et al. Kidney Int. 2009 Jan;75(2):185-96. doi: 10.1038/ki.2008.457. Epub 2008 Sep 17. Kidney Int. 2009. PMID: 18800033
Chronic kidney disease growth factors in renal fibrosis.
Boor P, Floege J. Boor P, et al. Clin Exp Pharmacol Physiol. 2011 Jul;38(7):441-50. doi: 10.1111/j.1440-1681.2011.05487.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21276040 Review.
Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling.
Raffetseder U, Rauen T, Boor P, Ostendorf T, Hanssen L, Floege J, En-Nia A, Djudjaj S, Frye BC, Mertens PR. Raffetseder U, et al. Nephron Exp Nephrol. 2011;118(4):e100-8. doi: 10.1159/000324209. Epub 2011 Mar 2. Nephron Exp Nephrol. 2011. PMID: 21372592
597 results
Jump to page